Is RAD50 p.Asp1007Val (c.3020A>T) pathogenic?

RAD50 p.Asp1007Val (c.3020A>T) is classified Uncertain significance in RAD50 (ClinVar, Multiple submitters, 2 submitters; last evaluated 2023-10-08). AlphaMissense: likely pathogenic (0.599); Very rare (popmax 0.0011%, sas); Associated with hereditary neoplastic syndrome.

What condition is associated with RAD50 p.Asp1007Val (c.3020A>T)?

RAD50 p.Asp1007Val (c.3020A>T) is associated with hereditary neoplastic syndrome (ClinVar).

How common is RAD50 p.Asp1007Val (c.3020A>T) in the general population?

RAD50 p.Asp1007Val (c.3020A>T) is very rare (popmax 0.0011%, sas) (gnomAD).

What do computational predictors say about RAD50 p.Asp1007Val (c.3020A>T)?

AlphaMissense predicts likely pathogenic (score 0.599) — an in-silico prediction, not a clinical call.

RAD50 p.Asp1007Val

c.3020A>T · rs2479371796 · VCV2113042

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

AlphaMissense

likely pathogenic

0.599 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.0011%, sas)

Missense predictors

1/2 damaging

AlphaMissense, SaProt · REVEL no call

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.599	likely pathogenic
REVEL	0.512	indeterminate
SaProt	LLR -8.71	tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI	<0.2	all four deltas below 0.2 · A>G here scores Δ0.52 · evaluated, not missing
Constraint at this position
Conservation	phyloP 11	GERP 3.4, phastCons 1
Regional constraint	o/e 0.86	unconstrained · MANE · 47 kb · p 0.00013 · regional, not allelic
Overall
CADD	24.9	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0011% South Asian · 1/91,050 alleles

Overall 6.2e-05% 1/1,613,804 alleles · very rare exomes 1/1,461,466 · genomes 0/152,338 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: RAD50
Protein: p.Asp1007Val
Coding: c.3020A>T
MANE Select: NM_005732
dbSNP: rs2479371796
Type: single nucleotide variant
Location: chr5:132609380 (GRCh38)
Gene constraint: LOEUF 0.889 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
Structure: AlphaFold pLDDT 82.83 · 6 PDB

Full RAD50 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

RAD50 p.Asp1007= Likely benign ★★ same residue
RAD50 p.Asp1007Glu Uncertain significance ★ ⚠ same residue
RAD50 c.1051+1G>A Likely pathogenic ★★ same condition
RAD50 c.1052-1G>A Likely pathogenic ★★ same condition
RAD50 c.1052-1G>T Pathogenic/Likely pathogenic ★★ same condition
RAD50 c.1052-2A>C Likely pathogenic ★★ same condition
RAD50 c.1245+1G>A Pathogenic/Likely pathogenic ★★ same condition
RAD50 c.129+1G>A Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rad50-p-asp1007val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown